Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

WASHINGTON BIOTECHNOLOGY INC

UEI: ZUAKBD9JA9B3

WASHINGTON BIOTECHNOLOGY INC is a federal contractor, registered under UEI ZUAKBD9JA9B3. It has been awarded $67,250 in federal contracts. Primary work spans Biological Product (except Diagnostic) Manufacturing and Unknown NAICS. Top awarding agencies include Department Of Health And Human Services, Department Of Agriculture, and Department Of Veterans Affairs.

Contact Information

Registration and classification details

Registration

UEI Code

ZUAKBD9JA9B3

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

Key Performance Metrics

Awards Count

15

All time

Active

0

Currently performing

Completed

15

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by NAICS
Awards by Agency Over Time
Awards by Place of Performance

Compete with WASHINGTON BIOTECHNOLOGY INC

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for WASHINGTON BIOTECHNOLOGY INC

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in WASHINGTON BIOTECHNOLOGY INC's top NAICS codes and agencies

NAICS: 561990
New
Federal
Intent to Sole Source Fire Suppression and Emergency Response Service
Solicitation # 36C26326Q0635_1
The Department of Veterans Affairs, Network Contracting Office 23, intends to award a sole source contract to the City of Minneapolis for fire suppression and emergency response services at the Veterans Affairs Medical Center in Minneapolis, Minnesota, including buildings at Fort Snelling. This action is being taken under the authority of FAR 6.103-1 and FAR 12.102(a), as the government has determined that only one responsible source can satisfy the agency requirements. The contractor is required to provide 24/7 contractor owned and contractor operated services, including responses to fire alarms, hazardous material spills, confined space rescues, and elevator entrapments. Key performance requirements include maintaining a minimum of four certified professional firefighters and two fire pumper apparatus with at least 1200 gpm capacity, ensuring a maximum response time of eight minutes to any location on the campus. The contractor must adhere to NFPA, IFC, OSHA, and State of Minnesota standards, maintain a minimum ISO rating of 3, and hold mutual aid agreements with at least two other municipal fire departments. Deliverables include annual building inspections, a phase-in plan due within ten days of award, and a confined space rescue plan due within fourteen days of the notice of award. Interested parties wishing to challenge the sole source determination must submit a capabilities statement by October 23, 2026.
Department Of Veterans Affairs

POSTED

about 21 hours ago

DEADLINE

in 8 days
View Details
NAICS: 325414
Federal
Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC)
Solicitation # 12639527R0001
Solicitation 12639527R0001 is a request for proposals issued by the USDA Animal and Plant Health Inspection Service (APHIS) for an Indefinite Delivery Indefinite Quantity (IDIQ) contract. The requirement covers the purchase, storage, and production of Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC), the conversion of Government-owned VAC into usable finished vaccines, and the direct purchase of finished vaccines. The contract has a ceiling price of 800 million dollars and a long-term performance horizon, featuring five one-year ordering periods starting approximately December 1, 2026, with conversion and delivery of finished vaccines extending through November 30, 2044. The scope of work requires the contractor to produce VAC capable of yielding at least 1.0 million doses and maintain these materials on their premises under strict quality control and temperature standards. Because live FMDV is a Tier 1 Select Agent, the contractor must hold a select agent authorization issued by CDC/APHIS. Finished vaccines must be packaged to maintain temperatures between 2 to 8 degrees Celsius for 24 hours and include electronic temperature monitors. Award will be based on the most advantageous offer considering technical capability, past performance from the last five years, and fair and reasonable pricing. Proposals must be submitted electronically to Stephen Tees by November 10, 2026, at 1700 CT, organized into four separate volumes.
Mrpbs Minneapolis Mn

POSTED

15 days ago

DEADLINE

in 26 days
View Details